Skip to main content
logo
Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
118.68
+0.40 (0.34%)
Oct 19, 2026, 2:00 PM EDT - Market open

Revenue by Geography

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22 Apr '21 Mar '20 Mar '19 Mar '18 Apr '17 Apr '16 Mar '15 Mar '14 Mar '13
United States Net Revenue
997.62M982.18M1.01B
Japan Net Revenue
67.41M68.20M62.41M
Europe Net Revenue
189.67M185.02M175.66M
Asia Net Revenue
85.73M87.21M92.31M
Other Geographic Net Revenue
11.59M11.42M19.54M
Revenue (Total)
1.35B1.33B1.36B

Revenue Breakdown 3

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22 Apr '21 Mar '20 Mar '19 Mar '18 Apr '17 Apr '16 Mar '15 Mar '14 Mar '13
Plasma Revenue
-524.46M535.43M
Blood Center Revenue
-221.27M261.12M
Hospital Revenue
-588.30M564.27M
Revenue (Total)
1.35B1.33B1.36B

EBIT

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22 Apr '21 Mar '20 Mar '19 Mar '18 Apr '17 Apr '16 Mar '15 Mar '14 Mar '13
Plasma Segment Operating Income (Post-Q3 2025 Reporting)
-184.80M184.51M
Blood Center Segment Operating Income (Post-Q3 2025 Reporting)
-49.98M52.82M
Hospital Segment Operating Income (Post-Q3 2025 Reporting)
-103.74M88.98M
Operating Income (Total)
160.32M156.73M221.82M